Stock Chart
ENTA
Type: BUY wallstreet
Strike: $18
Premium: $1.15
Expiry: Apr 17, 2026
Target: $19
Score: 41
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About ENTA - Enanta Pharmaceuticals, Inc
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed …
Key Statistics
More ENTA Analysis
This ENTA stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track ENTA's price movements with trendlines, gamma walls, and key support/resistance levels.